newsfilter
← Latest News
PR Newswire·

NEREUS™ - The Goat of Biscayne Bay Arrives for Miami Art Week

  • Vanda Pharmaceuticals Inc. announced the launch of the "NEREUS™ – The Goat of Biscayne Bay" floating activation during Miami Art Week on Nov. 11, 2026.
  • The event promotes NEREUS™ (tradipitant), the first new prescription treatment for motion-induced vomiting in over 40 years, which was approved in December 2025.
  • The activation targets travelers, creatives, & boat users navigating Biscayne Bay to highlight the medication's ability to prevent vomiting during water travel.
  • NEREUS™ is an oral NK-1 receptor antagonist available by prescription through participating retail pharmacies or directly via nereus.us.
  • Important safety information states NEREUS™ may impair driving or operating heavy machinery, especially when combined with sedatives or strong CYP3A4 inhibitors.
  • Common side effects include drowsiness, headache, & fatigue; the drug is not recommended for patients with liver problems, severe kidney issues, or children.
  • Vanda Pharmaceuticals advises pregnant women, breastfeeding mothers, & patients with liver or kidney conditions to consult healthcare providers before use.
  • Vanda established a contact number (1-844-GO-VANDA) for reporting side effects to the FDA or the company directly.
Company
Vanda Pharmaceuticals Inc.
Keywords
Vanda Pharmaceuticals Inc.